IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating Integra LifeSciences Holdings Corporation for potential violations of securities laws related to misleading statements and undisclosed information affecting investors [1][2]. Financial Performance - Integra reported a significantly larger loss per share in Q1 2025 compared to the same period in the previous year [2]. - The company provided full-year earnings guidance and Q2 revenue outlook that fell short of consensus estimates [2]. - The financial results were attributed to inventory issues and slower customer ordering patterns [2]. - Following the announcement, shares of Integra dropped by more than 21.1% on the same day [2].